Learn about proven results with ADAKVEO® (crizanlizumab-tmca)
For US residents only
Sickle cell pain crises are also known as pain crisis and are sudden and unpredictable episodes (crises) that can last, on average, 10 days.
Pain crises in the clinical trial were defined as painful episodes leading to a health care visit (emergency room [ER], clinic, hospital, or local physician visit).
The following health conditions were also considered pain crises if they led to a health care visit:
The efficacy of ADAKVEO on chronic pain was not studied in SUSTAIN.
It's important to speak to your health care providers regularly about your condition. Between visits, keep track of each pain crisis you have, even the ones you manage at home.
Watch patients with sickle cell disease describe their treatment experiences with ADAKVEO